Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT06770764 · RECRUITING
Trial details
- NCT number
- NCT06770764
- Sponsor
- Trutino Biosciences Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2027-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.